135 related articles for article (PubMed ID: 36582160)
1. [Intravenous thrombolytic therapy of ischemic stroke with the drug Revelisa in real clinical practice: results of the IVT-AIS-R study].
Soldatov MA; Klimov LV; Tolmachev AP; Kiseleva TV; Androfagina OV; Beketova EM; Belkina SN; Borisov DN; Karpov DY; Krasyuk MS; Kucheryavaya MV; Minina YD; Novikov DG; Rogozhnikova NV; Tabakman SV; Teliatnik YA; Tretyakov KV; Fadeeva AS; Khan DS; Chirkov AN; Marskaya NA; Shamalov NA
Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(12. Vyp. 2):42-49. PubMed ID: 36582160
[TBL] [Abstract][Full Text] [Related]
2. [Intravenous thrombolytic therapy with Revelisa of ischemic stroke in real-world clinical practice: interim results of an open-label, prospective, multicenter, non-interventional study IVT-AIS-R].
Soldatov MA; Marskaya NA; Barsegova KA; Androfagina OV; Borisov DN; Karpov DY; Kishinevsky MV; Kucheryavaya MV; Tabakman SV; Telyatnik YA; Fadeeva AS; Khan DS; Chirkov AN; Shamalov NA
Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(3. Vyp. 2):33-37. PubMed ID: 33908230
[TBL] [Abstract][Full Text] [Related]
3. [Experience of using a Russian alteplase product as thrombolytic therapy in patients with ischemic stroke in routine practice].
Murtazalieva DM; Zakaryaeva AR; Soshina TD; Zolotov MA; Parfenov VA
Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(8. Vyp. 2):55-59. PubMed ID: 37682096
[TBL] [Abstract][Full Text] [Related]
4. [Independence of ischemic stroke patients after alteplase systemic thrombolytic therapy].
Belkina SN; Kotov SV; Isakova EV; Kotov AS
Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(12. Vyp. 2):56-61. PubMed ID: 35044127
[TBL] [Abstract][Full Text] [Related]
5. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
[TBL] [Abstract][Full Text] [Related]
6. [Comparative characteristics of the efficacy and safety of the original alteplase and its complete biosimilar in the treatment of ischemic stroke in real clinical practice].
Marchenko SV; Hil UV; Hil IG
Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(3. Vyp. 2):49-54. PubMed ID: 38512095
[TBL] [Abstract][Full Text] [Related]
7. Changes in Activated Thrombin-Activatable Fibrinolysis Inhibitor Levels Following Thrombolytic Therapy in Ischemic Stroke Patients Correlate with Clinical Outcome.
Alessi MC; Gaudin C; Grosjean P; Martin V; Timsit S; Mahagne MH; Larrue V; Sibon I; Zuber M; Brouns R; Montaner J; Castellanos M; Donazzolo Y; Cho TH; Suissa L; Mechtouff L; Derex L; Suchon P; Mezzapesa A; Nighoghossian N
Cerebrovasc Dis; 2016; 42(5-6):404-414. PubMed ID: 27387478
[TBL] [Abstract][Full Text] [Related]
8. Effect of intravenous thrombolysis in acute ischemic stroke patients with cerebral microbleeds and analysis of risk factors for hemorrhagic transformation.
Lei YS; Li H; Lei JY; Li SX; Li DF
Eur Rev Med Pharmacol Sci; 2022 Feb; 26(3):779-786. PubMed ID: 35179744
[TBL] [Abstract][Full Text] [Related]
9. Intravenous Thrombolysis in Patients 90 Years or Older with Moderate to Severe Acute Ischemic Stroke Increases Ambulation at Discharge and Is Safe: A Prospective Cohort Study from a Single Center in Santiago, Chile.
González PE; Lavados PM; Aguirre AI; Brunser AM; Olavarría VV
Cerebrovasc Dis Extra; 2024; 14(1):16-20. PubMed ID: 38185102
[TBL] [Abstract][Full Text] [Related]
10. Early and continuous neurologic improvements after intravenous thrombolysis are strong predictors of favorable long-term outcomes in acute ischemic stroke.
Yeo LL; Paliwal P; Teoh HL; Seet RC; Chan BP; Wakerley B; Liang S; Rathakrishnan R; Chong VF; Ting EY; Sharma VK
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e590-6. PubMed ID: 23954601
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy and safety of non-immunogenic staphylokinase in the ischemic stroke in real-world clinical practice in the Sverdlovsk region].
Alasheev AM; Lantsova EV; Tretyakov DA
Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(7):74-79. PubMed ID: 37490668
[TBL] [Abstract][Full Text] [Related]
12. Thrombolytic therapy in acute ischemic stroke in Asia: The first prospective evaluation.
Suwanwela NC; Phanthumchinda K; Likitjaroen Y
Clin Neurol Neurosurg; 2006 Sep; 108(6):549-52. PubMed ID: 16289309
[TBL] [Abstract][Full Text] [Related]
13. [Older age is not related to hemorrhagic transformation and favorable outcomes in patients with wake-up ischemic stroke undergoing intravenous thrombolytic therapy].
Zhai LP; Chen ZC; Yan SQ; Zhong GL; Zhang S; Xu MJ; Lou M
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2015 Nov; 44(6):638-44. PubMed ID: 26822046
[TBL] [Abstract][Full Text] [Related]
14. Improvement of Functional Outcomes in Patients with Stroke who Received Alteplase for Over 15 Years: Japan Stroke Data Bank.
Ishigami A; Toyoda K; Nakai M; Yoshimura S; Wada S; Sasahara Y; Sonoda K; Miwa K; Koge J; Shiozawa M; Iwanaga Y; Miyamoto Y; Nakahara J; Suzuki N; Kobayashi S; Minematsu K; Koga M
J Atheroscler Thromb; 2024 Jan; 31(1):90-99. PubMed ID: 37587045
[TBL] [Abstract][Full Text] [Related]
15. Nonatrial Fibrillation was Associated With Early Neurological Improvement After Intravenous Thrombolysis With rt-PA in Patients With Acute Ischemic Stroke.
Liu J; Huang J; Xu H; Dai H
Neurologist; 2020 Mar; 25(2):28-32. PubMed ID: 32132497
[TBL] [Abstract][Full Text] [Related]
16. Iodinated Contrast Agents Reduce the Efficacy of Intravenous Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke Patients: a Multicenter Cohort Study.
Chen Z; Xu C; Zhong W; Gong X; Hu H; Zhang X; Chen Y; Li Q; Luo Z; Chen Z; Lou M
Transl Stroke Res; 2021 Aug; 12(4):530-539. PubMed ID: 32895894
[TBL] [Abstract][Full Text] [Related]
17. The association of admission ionized calcium with outcomes of thrombolysed patients with anterior circulation ischemic stroke.
Qi YL; Wu Q; Li XQ; Zhou ZH; Xia C; Wang XH; Chen HS
Brain Behav; 2023 Jan; 13(1):e2844. PubMed ID: 36479811
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of serum MDA and 4-HNE levels on the occurrence of early neurological deterioration after intravenous thrombolysis with rt-PA IVT in patients with acute ischemic stroke.
Zhang L; Li D; Zhang C; Zhang J; Xu J; Bai L; Xu J; Wang C
J Stroke Cerebrovasc Dis; 2024 Apr; 33(4):107574. PubMed ID: 38214238
[TBL] [Abstract][Full Text] [Related]
19. Multicenter Study of Intravenous Recombinant Tissue Plasminogen Activator Infusion around Hiroshima, Japan: The Hiroshima Acute Stroke Retrospective and Prospective Registry Study.
Aoki S; Hosomi N; Sueda Y; Kono T; Takamatsu K; Ohyama H; Torii T; Kitamura T; Nomura E; Noda K; Ohtsuki T; Matsumoto M;
J Stroke Cerebrovasc Dis; 2015 Dec; 24(12):2747-53. PubMed ID: 26360972
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of intravenous r-tPA versus UK for acute ischaemic stroke: a nationwide prospective Chinese registry study.
Wang X; Li X; Xu Y; Li R; Yang Q; Zhao Y; Wang F; Sheng B; Wang R; Chen S; Wang L; Shen L; Hou X; Cui Y; Wang D; Peng B; Anderson CS; Chen H;
Stroke Vasc Neurol; 2021 Dec; 6(4):603-609. PubMed ID: 33903179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
